Anti-Acid sphingomyelinase antibody [EPR23090-181] - BSA and Azide free
- KO Validated
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(0 Publication)
Rabbit Recombinant Monoclonal ASM antibody. Carrier free. Suitable for WB and reacts with Human samples.
View Alternative Names
ASM, SMPD1, Sphingomyelin phosphodiesterase, Acid sphingomyelinase, aSMase
- WB
Lab
Western blot - Anti-Acid sphingomyelinase antibody [EPR23090-181] - BSA and Azide free (AB273510)
This data was developed using the same antibody clone in a different buffer formulation (ab272729).
Western blot : Rabbit Monoclonal[EPR23090-181] to Acid sphingomyelinase ab272729 staining at 1/1000 dilution, shown in green; Mouse anti GAPDH (ab8245) loading control staining at 1/20,000 dilution, shown in magenta. A band was observed at 74 kDa in Wild-type MCF7 cell lysates with no signal observed at this size in SMPD1 knockout MCF7 cell line (ab326026). To generate this image, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3 % Milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit 800CW & Goat anti-Mouse 680RD at 1/20,000 dilution.
All lanes:
Western blot - Anti-Acid sphingomyelinase antibody [EPR23090-181] (<a href='/en-us/products/primary-antibodies/acid-sphingomyelinase-antibody-epr23090-181-ab272729'>ab272729</a>) at 1/1000 dilution
Lane 1:
Wild-type MCF7 at 20 µg
Lane 2:
Western blot - Human SMPD1 knockout MCF7 cell line (<a href='/en-us/products/cell-lines/human-smpd1-knockout-mcf7-cell-line-ab326026'>ab326026</a>) at 20 µg
Lane 3:
HeLa at 20 µg
Lane 4:
Ramos at 20 µg
Secondary
All lanes:
Goat anti-Rabbit 800CW & Goat anti-Mouse 680RD at 1/20000 dilution
Predicted band size: 70 kDa
Observed band size: 74 kDa
false
- WB
Lab
Western blot - Anti-Acid sphingomyelinase antibody [EPR23090-181] - BSA and Azide free (AB273510)
Blocking and diluting buffer and concentration : 5% NFDM/TBST
Diluting buffer and concentration.
This blot was developed using a higher sensitivity ECL substrate.
Exposure time : 3 minutes.
This data was developed using the same antibody clone in a different buffer formulation containing PBS, glycerol, BSA and sodium azide (ab272729).
All lanes:
Western blot - Anti-Acid sphingomyelinase antibody [EPR23090-181] (<a href='/en-us/products/primary-antibodies/acid-sphingomyelinase-antibody-epr23090-181-ab272729'>ab272729</a>) at 1/500 dilution
All lanes:
Human heart tissue lysate at 10 µg
Secondary
All lanes:
Western blot - VeriBlot for IP Detection Reagent (HRP) (<a href='/en-us/products/reagents/veriblot-for-ip-detection-reagent-hrp-ab131366'>ab131366</a>) at 1/1000 dilution
Predicted band size: 70 kDa
Observed band size: 75 kDa
false
- WB
Lab
Western blot - Anti-Acid sphingomyelinase antibody [EPR23090-181] - BSA and Azide free (AB273510)
This data was developed using the same antibody clone in a different buffer formulation (ab272729)
ab273510 was shown to react with SMPD1 in wild-type U-87 MG cell culture media in Western blot with loss of signal observed in a SMPD1 siRNA knockdown cell culture media. Cell culture media from wild-type U-87 MG transfected with either scrambled siRNA or SMPD1 siRNA were subjected to SDS-PAGE. Membranes were blocked in 5% milk in TBST for 1 hr before incubation with ab272729 overnight at 4 °C at a 1/1000 dilution. Blots were incubated with secondary antibodies at 0.2 µg/mL before imaging.
This data was provided by YCharOS Inc., an open science company with the mission of characterizing commercially available antibody reagents for all human proteins. Abcam and YCharOS are working together to help address the reproducibility crisis by enabling the life science community to better evaluate commercially available antibodies.
All lanes:
Western blot - Anti-Acid sphingomyelinase antibody [EPR23090-181] (<a href='/en-us/products/primary-antibodies/acid-sphingomyelinase-antibody-epr23090-181-ab272729'>ab272729</a>) at 1/1000 dilution
Lane 1:
Wild-type U-87 MG transfected with scrambled siRNA control cell culture media at 10 µg
Lane 2:
U-87 MG transfected with siRNA specifically targeting SMPD1 cell culture media at 10 µg
Observed band size: 75 kDa
false
Related conjugates and formulations (1)
-
Anti-Acid sphingomyelinase antibody [EPR23090-181]
Reactivity data
Product details
ab273510 is the carrier-free version of ab272729.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Conjugation ready
Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications.
Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.
Compatibility
This product is compatible with the Maxpar® Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar® is a trademark of Fluidigm Canada Inc.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
ASMase plays a role in membrane microdomain composition through its involvement in ceramide production. It participates in generating ceramide-enriched platforms that facilitate the clustering of signaling molecules. Ceramide acts as a second messenger in multiple cellular processes including apoptosis proliferation and inflammation. ASMase operates in the lysosomal lipid degradation pathway and connects with other lysosomal enzymes to modulate lipid turnovers such as glucosylceramidase affecting downstream cellular functions.
Pathways
Sphingolipid metabolism involves ASMase. This enzyme participates in the ceramide signaling pathway influencing apoptosis and stress responses. Related proteins in this pathway include casein kinase II which phosphorylates ASMase and cathepsin D involved in the lysosomal degradation process. ASMase activity alters ceramide levels impacting pro-apoptotic and pro-survival signals mediated by related proteins in the cell signaling network.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com